Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026

Go back to Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026
(NASDAQ: KRYS) Delayed: 337.37 -1.38 (0.41%)
Previous Close $338.75    52 Week High
Open $340.00    52 Week Low
Day High $341.35    P/E N/A 
Day Low $335.50    EPS
Volume 107,041